Earlier studies demonstrated the detrimental effects of TNF-α in IBD and that the blockade of this cytokine was effective in ameliorating the severity of colitis in both the T cell transfer (43) and the DSS mouse models (44). The gene discussed is TNF; the disease is inflammatory bowel disease.